Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ilaprazole in Peptic Ulcer Bleeding
NCT03362281Phase 3Completed
- Sponsor
- Livzon Pharmaceutical Group Inc.
- Start
- Oct 2014
- Primary completion
- Apr 2015
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of ilaprazole in Peptic ulcer hemorrhage (PUB) (2 arms), sponsored by Livzon Pharmaceutical Group Inc. Primary endpoint: Rate of Hemostasis at 72 hours. Started Oct 2014; status: completed.
02
Drugs
ilaprazole
03
Conditions
Peptic ulcer hemorrhage (PUB)
Beyond the preview
Go deeper on NCT03362281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03362281.